During one of the most critical periods of the global pandemic, Ellume’s over-the-counter, fully at-home COVID-19 diagnostic test became the first of its kind to be granted Emergency Use Authorisation by the US Food and Drug Administration (FDA).
Speed was of the essence when AstraZeneca asked us to help enhance the efficiency of vital COVID-19 testing as the pandemic swept the United Kingdom during the summer of 2020.
The call from the UK Government came in the late afternoon of Friday the 13th of March. Faced with the biggest health crisis in living memory, there was a risk that the nation’s ventilator capacity would be overwhelmed. This is the story of our response.
We began our relationship with Saranas back in 2015, as the Texas-based start-up set out on its mission to improve patient outcomes by detecting internal bleeding complications early. Half a decade on, we’re proud of our contribution to its Early Bird Bleed Monitoring System.
Speed of diagnosis is critical element to positive patient outcomes. The need for faster diagnostic devices must be met with-cost effective solutions that can be brought to market quickly.